| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2022 | Oct 7, 2022 | Ocugen, Inc. | Director | Sell | 15.0 | -4,500 | -100.00% | ✓ | $8.2K |
| Jul 18, 2022 | Jul 20, 2022 | Ocugen, Inc. | Director | Sell | 13.8 | -7,500 | -100.00% | ✓ | $19.3K |
| Apr 18, 2022 | Apr 20, 2022 | Ocugen, Inc. | Director | Sell | 13.8 | -7,500 | -100.00% | ✓ | $21.2K |
| Jan 18, 2022 | Jan 20, 2022 | Ocugen, Inc. | Director | Sell | 13.8 | -7,500 | -100.00% | ✓ | $30.5K |
| Oct 18, 2021 | Oct 20, 2021 | Ocugen, Inc. | Director | Sell | 10.0 | -7,500 | -100.00% | ✓ | $61K |
| Jul 19, 2021 | Jul 21, 2021 | Ocugen, Inc. | Director | Sell | 13.8 | -7,500 | -100.00% | ✓ | $48K |
| Apr 19, 2021 | Apr 21, 2021 | Ocugen, Inc. | Director | Sell | 13.8 | -7,500 | -100.00% | ✓ | $40K |
| Apr 26, 2017 | Apr 28, 2017 | Traws Pharma, Inc. | CEO | Buy | 95.0 | +23,810 | 30.36% | ✗ | $50K |
| Feb 7, 2014 | Feb 11, 2014 | Traws Pharma, Inc. | CEO | Sell | 30.0 | -33,543 | -5.72% | ✓ | $505.6K |
| Jan 30, 2014 | Feb 3, 2014 | Traws Pharma, Inc. | CEO | Sell | 30.0 | -60,000 | -6.75% | ✓ | $903K |
| Nov 15, 2013 | Nov 18, 2013 | Traws Pharma, Inc. | CEO | Buy | 61.3 | +1,100 | 0.40% | ✗ | $13.2K |
| Jul 30, 2013 | Aug 1, 2013 | Traws Pharma, Inc. | CEO | Buy | 82.5 | +6,667 | 2.48% | ✗ | $100K |